In this issue:
- PET-CT and 5-year progression of asymptomatic TB
- TST with follow-on IGRA to improve household contact TB screening
- Role of key comorbidities in unfavourable treatment outcomes in drug-sensitive pulmonary TB
- Incident TB in people with HIV across Europe
- WGS strategy for shortening treatment for rifampicin resistant TB
- 6-month strategy for rifampicin-resistant TB
- Higher levofloxacin doses for multidrug resistant TB
- H56:IC31 vaccine for reducing recurrence after successful treatment of drug-susceptible pulmonary TB
- Consensus on managing refractory nontuberculous mycobacterial pulmonary disease
- Antimicrobials for mild M. avium complex pulmonary disease: survival and QALYs
- Impact of treatment outcome on mortality in M. abscessus complex pulmonary disease
- Progression of nontuberculous mycobacterial pulmonary disease
Please login below to download this issue (PDF)